Cover Image
市場調查報告書

基因改造的皮膚替代品:治療方法、市場、策略與預測

Bioengineered Skin Substitutes to 2018 - Therapeutics, Markets, Strategies and Forecasts

出版商 Greystone Research Associates 商品編碼 240075
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
基因改造的皮膚替代品:治療方法、市場、策略與預測 Bioengineered Skin Substitutes to 2018 - Therapeutics, Markets, Strategies and Forecasts
出版日期: 2014年04月26日 內容資訊: 英文
簡介

本報告提供基因改造的皮膚替代品的市場相關調查分析、市場背景、皮膚替代品的主要產品及技術概要、各治療種類的市場機會分析、企業化的各種課題、市場影響因素分析、產品及技術的發展前景與市場規模的轉變與預測,及主要企業簡介等彙整,為您概述為以下內容。

摘要整理

高級轉基因細胞市場動態

  • 市場區隔
    • 急性創傷
    • 慢性創傷、潰瘍
    • 手術疤痕
    • 燒燙傷
  • 市場與患者的人口動態
    • 市場動態
    • 阻礙成長要素
  • 產業簡介
    • 產業結構
    • 競爭環境
    • 技術市場成長推進因素

基因改造皮膚替代品產品分析

  • 無細胞基質
  • 同種異體基質
  • 同種異體片
  • 雙層替代皮膚
  • 生物可吸收性支架
  • 細胞外基質(ECM)
  • 膠原蛋白生物薄膜
  • 異種移植
  • FDA未核準的皮膚替代品

市場部門的資料、評估與預測

  • 急性外傷
  • 燒燙傷
  • 糖尿病性潰瘍
  • 壓迫性潰瘍
  • 靜脈潰瘍

商務部門的策略和風險

  • 專用技術
  • 短期性的資本化
  • 策略性聯盟&聯盟
  • 開發現階段的轉變要素
  • 促成科技

市場影響因素

  • 臨床實驗要素
  • FDA指南
  • 給付
  • 患者人口動態的變化
  • POC(重點照護)的治療
  • 通訊協定和試驗指標

相關經營者簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ESK698F

Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world's leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin.

Highlights

  • Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for replacing or augmenting damaged or diseased skin
  • Provides detailed analysis of bioengineered skin substitute products
  • Assesses business risk factors and market issues
  • Analyzes technology and product developments, and provides forecasts through 2018
  • Profiles bioengineered skin substitute companies, their product development activities, and strategies

What You Will Learn

  • What are the key segments and patient demographics that comprise the market for engineered skin substitutes?
  • What are the major therapeutic demand drivers for bioengineered skin substitutes?
  • What are the design factors, material selection issues and technologies that are being used in commercial and development-stage engineered skin substitute products?
  • What is the market share and product position in the market and what will it look like in 2018?
  • Who are the companies behind the current generation of bioengineered skin substitutes and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging bioengineered skin substitutes?
  • What is the impact of economic, technology, and regulatory factors?

Table of Contents

Executive Summary

Advanced Bioengineered Tissue Market Dynamics

  • Market Segmentation
    • Acute Wounds
    • Chronic Wounds & Ulcers
    • Surgical Wounds
    • Burns
  • Market and Patient Demographics
    • Market Dynamics
    • Factors Limiting Growth
  • Industry Profile
    • Industry Structure
    • Competitive Landscape
    • Technology Market Drivers

Bioengineered Skin Substitute Product Analysis

  • Acellular Matrices
  • Allogeneic Matrices
  • Allogeneic Sheets
  • Bilayered Skin Substitutes
  • Bioabsorbable Scaffolds
  • Extracellular Matrix
  • Collagen Biomembranes
  • Xenografts
  • Non-FDA Cleared Skin Substitutes
    • Extracellular Matrices
    • Cultured Epidermal Autografts

Market Sector Data, Assessments & Forecasts

  • Acute Trauma
  • Burns
  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers

Business Sector Strategies and Risks

  • Proprietary Technology
  • Near-term Capitalization
  • Strategic Alliances & Partnerships
  • Development Stage Transition Factors
  • Enabling Technologies

Market Factors

  • Clinical Trial Factors
  • FDA Guidelines
  • Reimbursement
  • Evolving Patient Demographics
  • Point-of-Care Processing
  • Protocols and End-Points

Company Profiles

Back to Top